About
M & A

M & A

Tracking M And A legal and regulatory developments.

7 entries in Tech Counsel Tracker

LawSnap Briefing Updated October 7, 2026

State of play.

Where things stand.

Latest developments.

Active questions and open splits.

  • Can state AGs block deals the DOJ has cleared? The Paramount–Warner litigation is the highest-stakes test of whether state antitrust authority under the Clayton Act can independently enjoin a transaction after federal regulators have concluded it is not anticompetitive. The answer will define the risk calculus for every large media and technology deal going forward (→ 12 State AGs Sue to Block $110B Paramount-Warner Bros. Discovery Merger, Twelve Blue States Sue to Block Paramount-Warner Bros. Discovery Merger After DOJ Clearance).
  • What remedies attach when a party circumvents a hold-separate order? The Nexstar–TEGNA court's characterization of the board maneuvers as "shocking" and "brazen" signals willingness to impose structural remedies beyond clarification — but the precise enforcement toolkit for hold-separate violations in pending M&A litigation is unsettled (→ California AG Says Nexstar and Tegna Are Violating Court’s Merger Block).
  • How does the $650 million quarterly ticking fee interact with Paramount's trial strategy? Paramount's decision to skip the preliminary-injunction stage extends the timeline by months; whether the ticking fee creates renegotiation pressure or triggers material adverse change analysis before trial is an open deal-structuring question (→ Paramount Skydance Goes to Trial to Try to Save Its Warner Bros. Deal).
  • What governance rights attach to OpenAI's foundation-control structure? The hybrid nonprofit-for-profit conversion — with the foundation retaining control and significant equity while investors hold rights at a $852 billion valuation — has no settled regulatory template; the California AG MOU conditions and Microsoft's renegotiated IP rights through 2032 are the only disclosed constraints (→ Wachtell’s Justin Orr honored after OpenAI recapitalization and fundraising work).
  • Does Nvidia's Lancium investment trigger CFIUS review or antitrust scrutiny? Vertical integration from chips into the power-infrastructure layer of a $500 billion government-backed AI initiative raises novel questions about market concentration in AI compute; neither Nvidia nor Lancium has confirmed the deal or disclosed a regulatory pathway (→ Nvidia reportedly plans up to $3B investment in Stargate power firm Lancium).
  • What diligence standard applies to concentrated, pre-revenue AI infrastructure investments? Source Foundry — incorporated July 2025, valued at $5 billion, no disclosed technical roadmap or regulatory filings — received $500 million from a fund that was near collapse weeks earlier; the governance terms, investor rights, and securities-law implications of the structure remain entirely opaque (→ Situational Awareness Puts $400M More Into Stealth Chip Startup Source Foundry).
  • How does Lower Saxony's blocking stake constrain VW restructuring options? The Porsche-Piëch families' public escalation strengthens management's hand, but Lower Saxony retains veto power over major decisions — creating a governance deadlock with direct implications for creditors, labor claimants, and any counterparty negotiating long-term supply or partnership agreements with VW .

What to watch.

  • Trial scheduling ruling in the Paramount–Warner litigation — whether the court sets a 2026 or 2027 date will determine whether the $650 million quarterly ticking fee becomes a deal-killer before the merits are reached.
  • Whether the Nexstar–TEGNA court imposes structural board remedies following its "shocking" and "brazen" characterization — the first major enforcement ruling on hold-separate order violations in a pending media merger.
  • Regulatory approval process for Visa–BioCatch: any conditions imposed on cross-border behavioral biometrics data sharing will become the template for fintech acquisitions involving Israeli targets.
  • Whether Nvidia and Lancium publicly confirm the reported $3 billion investment and disclose a CFIUS filing or regulatory pathway — the absence of confirmation leaves the deal's antitrust and national security treatment entirely open.
  • OpenAI's path toward IPO: any S-1 filing will be the first public disclosure of the foundation-control governance structure, Microsoft IP arrangements, and investor rights at the $852 billion valuation — documents that will immediately become drafting references for AI sector transactions.
  • Whether additional state AGs join the Paramount–Warner coalition or file parallel actions, which would signal that the decoupling of state and federal antitrust enforcement in media M&A is structural rather than episodic.

7 Contributing Entries

AI labs turn rivals into compute suppliers as shortage pushes deals like Anthropic-xAI

Major AI developers are short on computing capacity, and executives are now personally deciding how it gets allocated, according to a Wall Street Journal report. Rivals are forming alliances to secure supply. The clearest case is Anthropic, which agreed to buy compute through xAI's Colossus clusters through May 2029 at roughly $1.25 billion a month, according to a SpaceX IPO filing. xAI is now part of SpaceX and competes directly with Anthropic. OpenAI also finalized a deal to use Google Cloud for additional capacity despite its rivalry with Google's Gemini models. Nvidia is reportedly in talks to acquire Reflection AI, possibly through an acqui-hire.

October 10, 2026
Details arrow_forward

Pfizer CEO Bourla Hands AI Decisions to Business Unit Heads After Slow Two-Year Rollout

Pfizer is restructuring how it runs artificial intelligence, shifting decisions from a central team of specialists to the business leaders closest to each domain. CEO Albert Bourla told the Wall Street Journal's CEO Brief that the change reverses his earlier approach, which he said had stalled. He described progress under the old model as "stagnation," despite two years of enterprise-wide AI integration. Under the new setup, domain leaders make the AI calls and are accountable for how workflows and operations change, while a central team provides support. Bourla says the move reduced internal resistance and sped adoption, and reporting describes cross-functional groups called "clans" that link departments. The story was reported October 9, 2026.

October 9, 2026
Details arrow_forward

California expands PFAS fraud case against DuPont spinoffs over asset transfers

California Attorney General Rob Bonta filed a Second Amended Complaint in the state's PFAS litigation, alleging that DuPont-related companies executed fraudulent asset transfers designed to shield themselves from environmental liability. The complaint targets E. I. du Pont de Nemours and Company, DuPont de Nemours, Inc., Corteva, Inc., The Chemours Company, and newly created Qnity Electronics. Bonta contends that corporate restructuring and amended agreements shifted the bulk of PFAS-related liabilities onto Chemours while reducing exposure for New DuPont, Corteva, and Qnity Electronics. The filing invokes the Uniform Fraudulent Transfer Act and the Uniform Voidable Transactions Act, and seeks relief in U.S. District Court for the District of South Carolina.

UN releases 2026 International AI Safety Report warning of enormous benefits and existential risks

The United Nations released the International AI Safety Report 2026, a comprehensive assessment concluding that advanced artificial intelligence presents both transformative opportunities and escalating dangers. The report, led by the UN agency for digital technology, finds that AI can accelerate development in health, education, and financial services in developing nations while simultaneously enabling cyberattacks, deepfake fraud, non-consensual intimate imagery, and biological weapon design. The core finding: AI capabilities in critical fields like biological research are advancing faster than governance frameworks, creating a dangerous gap between what is technologically possible and what remains safe.

Revolut wins French banking licence to expand across Western Europe

Revolut has secured a full banking licence from France's banking regulator, the ACPR, with approval from the European Central Bank. The London-based fintech will operate through a new French entity, Revolut Bank S.A., enabling it to offer lending, deposits, regulated savings products, and mortgages in France. The company plans to expand the French operation across Germany, Ireland, Italy, Portugal, and Spain, while maintaining its existing EU banking base in Lithuania for the remainder of the EEA.

August 10, 2026
Details arrow_forward

Aavalynx raises £1.5M pre-seed to expand AI dispute-insights platform

Aavalynx, a Jersey-based legaltech startup, has raised £1.5 million in pre-seed funding to expand its AI platform for dispute resolution. The round was led by European Omega Ventures, with participation from Two Ravens and angel investors including senior law firm partners and a former Amazon Europe executive. Founders Hanna Roos and Lauri Hyry launched Sisu, an analytics platform that processes litigation and dispute data to help enterprises forecast legal exposure, accelerate strategic decisions, and manage legal spend at scale.

mail Subscribe to M & A email updates

Primary sources. No fluff. Straight to your inbox.

Also on LawSnap